- If you are trying to work out whether BioNTech’s share price still reflects its true worth, you are not alone. This article is going to focus squarely on what you are paying versus what you are getting.
- BioNTech’s stock last closed at US$100.76, with returns of 4.2% year to date, alongside declines of 9.1% over the past week, 11.4% over the past month, 8.1% over the past year and 21.9% over three years. This raises questions about how the market is currently pricing its prospects.
- Recent news around BioNTech has centered on its position in pharmaceuticals and biotech, including ongoing attention on its mRNA technology and its role in vaccines and therapeutics. This keeps investor focus on how durable its business model could be. These…
10 Top Debit & Credit Picks in 2026
March 5, 2026
